Literature DB >> 27519130

Type 2 Diabetes Treatment in the Patient with Obesity.

Steven K Malin1, Sangeeta R Kashyap2.   

Abstract

Lifestyle modification is the cornerstone treatment of type 2 diabetes in the obese patient, and is highly effective at promoting glucose regulation. However, many individuals struggle over time to maintain optimal glycemic control and/or body weight with lifestyle modification. Therefore, additional therapeutic approaches are needed. Pharmacologic interventions have shown promising results for obesity-related diabetes complications. Not surprisingly though lifestyle modification and pharmacology may become ineffective for treating diabetes over time. Bariatric surgery is considered by some, but not all, to be the most effective and durable treatment for combating obesity. In fact many patients with type 2 diabetes have normalized glucose concentrations within days postoperation. Taken together, treatment of obesity in the patient with type 2 diabetes requires a multi-faceted approach.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Diet; Exercise; Glycemic control; Insulin resistance; Pharmacology; β-cell function

Mesh:

Substances:

Year:  2016        PMID: 27519130     DOI: 10.1016/j.ecl.2016.04.007

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

1.  Brown Adipose Tissue, Not Just a Heater.

Authors:  Lin Chang; Minerva T Garcia-Barrio; Y Eugene Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03       Impact factor: 8.311

2.  The Crosstalk between Cardiac Lipotoxicity and Mitochondrial Oxidative Stress in the Cardiac Alterations in Diet-Induced Obesity in Rats.

Authors:  Sara Jiménez-González; Gema Marín-Royo; Raquel Jurado-López; María Visitación Bartolomé; Ana Romero-Miranda; María Luaces; Fabián Islas; María Luisa Nieto; Ernesto Martínez-Martínez; Victoria Cachofeiro
Journal:  Cells       Date:  2020-02-17       Impact factor: 6.600

3.  Acute Metabolic Responses to Glucose and Fructose Supplementation in Healthy Individuals: A Double-Blind Randomized Crossover Placebo-Controlled Trial.

Authors:  Max L Eckstein; Antonia Brockfeld; Sandra Haupt; Janis R Schierbauer; Rebecca T Zimmer; Nadine Wachsmuth; Beate Zunner; Paul Zimmermann; Barbara Obermayer-Pietsch; Othmar Moser
Journal:  Nutrients       Date:  2021-11-16       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.